Plavix - clopidogrel bisulfate
Navigation: NDC > Supplier starting with: C > CARDINAL HEALTH| Field | Value |
|---|---|
| NDC Code: | 55154-2022 |
| Proprietary Name: | Plavix |
| Suffix: | |
| Non-Proprietary Name: | clopidogrel bisulfate |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 17-11-1997 |
| Category Name: | NDA |
| Application Number: | NDA020839 |
| Labeler: | CARDINAL HEALTH |
| Substance Name: | CLOPIDOGREL BISULFATE |
| Active Numerator Strength: | 300 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] |
| DEA Schedule: |